🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Martijn P. Lolkema

ORCID: 0000-0003-0466-2928

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial”.

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00757-9

N/A

4.9DataRank · unranked

188 citations

Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu +90 more

Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer

Nature Genetics(2021)10.1038/s41588-021-00874-3

N/A

0.772DataRank · unranked

171 citations

Kevin Anderson, Frederick S. Varn, Kevin C. Johnson, Samirkumar B. Amin, Erik P. Sulman +4 more

SARS-CoV-2 vaccination and phase 1 cancer clinical trials

The Lancet Oncology(2021)10.1016/s1470-2045(21)00017-6

N/A

0.385DataRank · unranked

12 citations

Lillian L. Siu, Emiliano Calvo, Martijn P. Lolkema, Patricia LoRusso, Jean‐Charles Soria +5 more

Germline determinants of the prostate tumor genome

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.16.516773

N/A

0DataRank · unranked

0 citations

Jiapei Yuan, Tommer Schwarz, Julie Livingstone, Natalie S. Fox, Weerachai Jaratlerdsiri +36 more